SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000932440-14-000176
Filing Date
2014-04-10
Accepted
2014-04-10 16:02:28
Documents
2
Group Members
RIDGEBACK CAPITAL INVESTMENTS LTD.RIDGEBACK CAPITAL MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g_2244937.htm SC 13G 141056
2 JOINT FILING AGREEMENT ex99-1_2244939.htm EX-99.1 14980
  Complete submission text file 0000932440-14-000176.txt   157675
Mailing Address 11801 RESEARCH DRIVE SUITE D ALACHUA FL 32615
Business Address 11801 RESEARCH DRIVE SUITE D ALACHUA FL 32615 386-462-2204
APPLIED GENETIC TECHNOLOGIES CORP (Subject) CIK: 0001273636 (see all company filings)

IRS No.: 593553710 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88071 | Film No.: 14757079
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011
Business Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011 212-624-2567
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G